Literature DB >> 10383558

Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.

R D Hain1, A Hardcastle, C R Pinkerton, G W Aherne.   

Abstract

AIMS: To measure morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children following a single intravenous dose of morphine.
METHODS: Twenty-nine paired samples of cerebrospinal fluid and plasma were collected from children with leukaemia undergoing therapeutic lumbar puncture. An intravenous dose of morphine was administered at selected intervals before the procedure. Concentrations of morphine and morphine-6-glucuronide (M6G) were measured in each sample. Morphine was measured using a specific radioimmunoassay (r.i.a.) and M6G was measured using a novel enzyme-linked immunosorbent assay (ELISA).
RESULTS: The ELISA for measuring M6G was highly sensitive. The intra-and interassay variations were less than 15%. Using a two-compartment model for plasma morphine, the area under the curve to infinity (AUC, 7143 ng ml-1 min), volume of distribution (3.6 l kg-1 ) and elimination half-life (88 min) were comparable with those reported in adults. Clearance (35 ml min-1 ) was higher than that in adults. Morphine-6-glucuronide was readily synthesized by the children in this study. The elimination half-life (321 min) and AUC (35507 ng ml-1 min) of plasma M6G were much greater than those of morphine.
CONCLUSIONS: Extensive metabolism of morphine to M6G in children with cancer has been demonstrated. These data provide further evidence to support the importance of M6G accumulation after multiple doses. There was no evidence that morphine passed more easily into the CSF of children than adults.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383558      PMCID: PMC2014881          DOI: 10.1046/j.1365-2125.1999.00948.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  46 in total

1.  Analgesic effect of morphine glucuronides.

Authors:  K Shimomura; O Kamata; S Ueki; S Ida; K Oguri; H Yoshimura; H Tsukamoto
Journal:  Tohoku J Exp Med       Date:  1971-09       Impact factor: 1.848

Review 2.  Multiple mu opiate receptors.

Authors:  G W Pasternak; P J Wood
Journal:  Life Sci       Date:  1986-05-26       Impact factor: 5.037

3.  A specific radioimmunoassay for the determination of morphine-6-glucuronide in human plasma.

Authors:  D J Chapman; M J Cross; S P Joel; G W Aherne
Journal:  Ann Clin Biochem       Date:  1995-05       Impact factor: 2.057

4.  Variation in morphine pharmacokinetics in children with cancer.

Authors:  M C Nahata; A W Miser; J S Miser; R H Reuning
Journal:  Dev Pharmacol Ther       Date:  1985

5.  Morphine glucuronidation in human fetal and adult liver.

Authors:  G M Pacifici; J Säwe; L Kager; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Pharmacokinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure.

Authors:  A R Aitkenhead; M Vater; K Achola; C M Cooper; G Smith
Journal:  Br J Anaesth       Date:  1984-08       Impact factor: 9.166

7.  CSF and plasma pharmacokinetics of intramuscular morphine.

Authors:  G Nordberg; L Borg; T Hedner; T Mellstrand
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Pharmacokinetics of intravenous morphine in balanced anesthesia: studies in children.

Authors:  H Vandenberghe; S Mac Leod; H Chinyanga; L Endrenyi; S Soldin
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

9.  Pharmacokinetics of intravenous morphine in patients anesthetized with enflurane-nitrous oxide.

Authors:  M R Murphy; C C Hug
Journal:  Anesthesiology       Date:  1981-03       Impact factor: 7.892

10.  Morphine kinetics in children.

Authors:  B Dahlström; P Bolme; H Feychting; G Noack; L Paalzow
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

View more
  11 in total

Review 1.  Strong opioids in pediatric palliative medicine.

Authors:  Richard D W Hain; Angela Miser; Mary Devins; W Hamish B Wallace
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 2.  Postoperative pain management in children and infants: an update.

Authors:  Christopher Brasher; Benjamin Gafsous; Sophie Dugue; Anne Thiollier; Joelle Kinderf; Yves Nivoche; Robert Grace; Souhayl Dahmani
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

3.  A mechanistic approach for the scaling of clearance in children.

Authors:  Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium.

Authors:  Tao Liu; Tamorah Lewis; Estelle Gauda; Jogarao Gobburu; Vijay Ivaturi
Journal:  J Clin Pharmacol       Date:  2016-02-22       Impact factor: 3.126

5.  Development and evaluation of a generic physiologically based pharmacokinetic model for children.

Authors:  Andrea N Edginton; Walter Schmitt; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 6.  Prediction of morphine clearance in the paediatric population : how accurate are the available pharmacokinetic models?

Authors:  Elke H J Krekels; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

Review 7.  Morphine-6-glucuronide: an analgesic of the future?

Authors:  J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

8.  Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery.

Authors:  O Dale; J Thoner; T Nilsen; T Tveita; P C Borchgrevink; P Klepstad
Journal:  Eur J Clin Pharmacol       Date:  2007-07-10       Impact factor: 2.953

9.  Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human Liver.

Authors:  Deepak Kumar Bhatt; Aanchal Mehrotra; Andrea Gaedigk; Revathi Chapa; Abdul Basit; Haeyoung Zhang; Prachi Choudhari; Mikael Boberg; Robin E Pearce; Roger Gaedigk; Ulrich Broeckel; J Steven Leeder; Bhagwat Prasad
Journal:  Clin Pharmacol Ther       Date:  2018-07-12       Impact factor: 6.875

10.  Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis.

Authors:  Laurens F M Verscheijden; Jan B Koenderink; Saskia N de Wildt; Frans G M Russel
Journal:  PLoS Comput Biol       Date:  2019-06-13       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.